PubMed中文版
| PubMed ID | 40749808 |
|---|---|
| 发表日期 | 2025-07-30 |
| 作者 | Wang M, Zhang L, Huang W, Huang J, Luo Y, Huang N. |
| 文献标题 | The potential of acupuncture in the treatment of Alzheimer's disease: An exploration from traditional Chinese medicine to modern technology. |
| 原始出处 | Complement Ther Med |
| 影响因子 | 3.5 期刊引文指标 0.93 |
| PubMed ID | 40629265 |
|---|---|
| 发表日期 | 2025-07-08 |
| 作者 | Wang J, Liu C, Dai Y, Mei C, Wang G, Wang Y, Huang T, Zhan J, Cheng J. |
| 文献标题 | Efficacy of music therapy as a non-pharmacological measure to support alzheimer's disease patients: a systematic review. |
| 原始出处 | BMC Geriatr |
| 影响因子 | 3.8 期刊引文指标 1.16 |
| PubMed ID | 40667684 |
|---|---|
| 发表日期 | 2025-07-01 |
| 作者 | Gueorguieva I, Chow K, Chua L, Shcherbinin S, Zimmer JA, Evans CD, Wang H, Nery ESM, Brooks DA, Sims JR. |
| 文献标题 | Donanemab exposure-response in early symptomatic Alzheimer's disease. |
| 原始出处 | Alzheimers Dement |
| 影响因子 | 11.1 期刊引文指标 3.34 |
| PubMed ID | 40709526 |
|---|---|
| 发表日期 | 2025-07-01 |
| 作者 | Sharma N, Kim D, Sharma H, Kim MI, Lee H, Kim M, Ryoo N, Kang MJ, Pyun JM, Park YH, Ryu J, Oh HJ, Yang HS, Kim HR, Kim GH, Han S, Yang Y, Youn YC, Teunissen C, Zetterberg H, Scheltens P, An SSA, Kim YB, Kim S, Alzheimer's Disease All Markers (ADAM) Research Group. |
| 文献标题 | Unveiling blood biomarkers for neuronal hyperplasticity: Insights from AD molecular subtyping, a comprehensive review. |
| 原始出处 | Alzheimers Dement |
| 影响因子 | 11.1 期刊引文指标 3.34 |
| PubMed ID | 40541584 |
|---|---|
| 发表日期 | 2025-06-18 |
| 作者 | Tao X, Wang L, Gong W. |
| 文献标题 | Untargeted metabolomics reveals the mechanisms of luteolin and exercise combination treatment against cognitive impairments in AD mice through modulating autophagy. |
| 原始出处 | J Nutr Biochem |
| 影响因子 | 4.9 期刊引文指标 1.08 |
| PubMed ID | 40532315 |
|---|---|
| 发表日期 | 2025-06-16 |
| 作者 | Wu QL, Yang X, Luo JX, Liu L, Zhou Y, Lu MH. |
| 文献标题 | Microglia energy metabolism: A new perspective on Alzheimer's disease treatment. |
| 原始出处 | J Neurol Sci |
| 影响因子 | 3.2 期刊引文指标 0.79 |
| PubMed ID | 40545559 |
|---|---|
| 发表日期 | 2025-06-01 |
| 作者 | Cummings J, Cohen S, Murphy J, Brothers HM, Nejati M, Forrestal F, de Moor C, O'Gorman J, Harrison J, Jaeger J, Mummery CJ, Porsteinsson AP, Potashman M, Tian Y, Yang L, He P, Haeberlein SB. |
| 文献标题 | Evaluation of cognitive, functional, and behavioral effects observed in EMERGE, a phase 3 trial of aducanumab in people with early Alzheimer's disease. |
| 原始出处 | Alzheimers Dement |
| 影响因子 | 11.1 期刊引文指标 3.34 |
| PubMed ID | 40448382 |
|---|---|
| 发表日期 | 2025-06-01 |
| 作者 | Tang H, Donahoo WT, DeKosky ST, Lee YA, Kotecha P, Svensson M, Bian J, Guo J. |
| 文献标题 | Heterogeneous treatment effects of GLP-1RAs and SGLT2is on risk of Alzheimer's disease and related dementia in patients with type 2 diabetes: Insights from a real-world target trial emulation. |
| 原始出处 | Alzheimers Dement |
| 影响因子 | 11.1 期刊引文指标 3.34 |
| PubMed ID | 40506692 |
|---|---|
| 发表日期 | 2025-06-01 |
| 作者 | Vigneswaran S, Vijverberg EGB, Barkhof F, van de Giessen E, Lemstra AW, Pijnenburg Y, Teunissen CE, van der Flier WM, van Harten AC. |
| 文献标题 | "Real-world" eligibility for anti-amyloid treatment in a tertiary memory clinic setting. |
| 原始出处 | Alzheimers Dement |
| 影响因子 | 11.1 期刊引文指标 3.34 |
| PubMed ID | 40245176 |
|---|---|
| 发表日期 | 2025-04-01 |
| 作者 | Liu Z, Zhang J, Jiang F, Liu C, Shao Y, Le W. |
| 文献标题 | Biological Effects of Dietary Restriction on Alzheimer's Disease: Experimental and Clinical Investigations. |
| 原始出处 | CNS Neurosci Ther |
| 影响因子 | 5 期刊引文指标 1.29 |
| PubMed ID | 40487537 |
|---|---|
| 发表日期 | 2025-04-01 |
| 作者 | Marotta C, Gonzalez-Ortiz F, Turton M, Zetterberg H, Harrison P, Hovens CM, Sinclair B, O'Brien TJ, Blennow K, Vivash L. |
| 文献标题 | Brain-derived tau to measure treatment effect in Alzheimer's disease and frontotemporal dementia. |
| 原始出处 | Alzheimers Dement (Amst) |
| 影响因子 | 4.4 期刊引文指标 1.21 |
| PubMed ID | 40463636 |
|---|---|
| 发表日期 | 2025-04-01 |
| 作者 | Iulita MF, Streel E, Harrison J. |
| 文献标题 | Digital biomarkers: Redefining clinical outcomes and the concept of meaningful change. |
| 原始出处 | Alzheimers Dement (N Y) |
| 影响因子 | 6.8 期刊引文指标 1.56 |
| PubMed ID | 40034522 |
|---|---|
| 发表日期 | 2025-01-31 |
| 作者 | Chaudhuri I, Das S. |
| 文献标题 | Heterogeneous treatment effects of BCG vaccine on Alzheimer's disease risk. |
| 原始出处 | J Alzheimers Dis Rep |
| 影响因子 | 2.8 期刊引文指标 0.63 |
| PubMed ID | 38757165 |
|---|---|
| 发表日期 | 2025-01-01 |
| 作者 | Singh D, Kurmi BD, Singh A. |
| 文献标题 | Graphene Oxide, a Prominent Nanocarrier to Reduce the Toxicity of Alzheimer's Proteins: A Revolution in Treatment. |
| 原始出处 | Recent Pat Nanotechnol |
| 影响因子 | 3.1 期刊引文指标 0.24 |
| PubMed ID | 40510745 |
|---|---|
| 发表日期 | 2025-01-01 |
| 作者 | Shan G, Zhang Y, Wang G. |
| 文献标题 | Comparison between treatment-placebo difference and saved time measures to assess treatment effect in Alzheimer's disease. |
| 原始出处 | J Alzheimers Dis Rep |
| 影响因子 | 2.8 期刊引文指标 0.63 |
| PubMed ID | 39665306 |
|---|---|
| 发表日期 | 2025-01-01 |
| 作者 | Zhang N, Nao J, Dong X. |
| 文献标题 | Efficacy and Safety of Natural Apigenin Treatment for Alzheimer's Disease: Focus on In vivo Research Advancements. |
| 原始出处 | Curr Neuropharmacol |
| 影响因子 | 5.3 期刊引文指标 0.86 |
| PubMed ID | 39651698 |
|---|---|
| 发表日期 | 2024-12-09 |
| 作者 | Cai J, Liu Y, Fan H. |
| 文献标题 | Review on pathogenesis and treatment of Alzheimer's disease. |
| 原始出处 | Dev Dyn |
| 影响因子 | 1.5 期刊引文指标 0.75 |
| PubMed ID | 39623797 |
|---|---|
| 发表日期 | 2024-12-02 |
| 作者 | Ding Q, Zhao Y, Xi E, Liu K, Gao N, Zhu G. |
| 文献标题 | Constructing a Metal-Organic Frameworks-Based Long-Acting Sequential Release System for the Treatment of Alzheimer's Disease. |
| 原始出处 | Adv Healthc Mater |
| 影响因子 | 9.6 期刊引文指标 1.37 |
| PubMed ID | 39637477 |
|---|---|
| 发表日期 | 2024-11-26 |
| 作者 | Abeysinghe S, Tao Y, Kyei-Baffour P, Adrion E. |
| 文献标题 | 'Small benefits and a certain risk': Media representations of novel treatments for Alzheimer's disease. |
| 原始出处 | Soc Sci Med |
| 影响因子 | 5 期刊引文指标 1.64 |
| PubMed ID | 39648108 |
|---|---|
| 发表日期 | 2024-11-19 |
| 作者 | Aga VM. |
| 文献标题 | Brexpiprazole for the Treatment of Agitation in Alzheimer's Disease Dementia: Clinical Uncertainties and the Path Forward. |
| 原始出处 | Am J Geriatr Psychiatry |
| 影响因子 | 3.8 期刊引文指标 1.25 |